UR

Umaben Rajankumar Thakar

Active Director Director DIN 09287998
DIN 09287998 First appointment Aug 2021 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2021
Shareholding value •••• Premium profile

About Umaben Rajankumar Thakar

Data last updated:

Umaben Rajankumar Thakar is a Director at Albero Pharma Private Limited (since 2021). The company operates in Pharma. Albero Pharma Private Limited reported revenue of ₹1.08 Cr (FY 2025).

DIN 09287998
Primary Designation Director
Industry Pharma
First Appointment 19 Aug 2021
Oldest Company Age 8 yrs
Largest company Albero Pharma Private Limited · ₹1.08 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Albero Pharma Private Limited U33112GJ2018PTC104775
Director19 Aug 20212018₹1.08 Cr (FY 2025)Active

Directorship timeline

Open interactive timeline →
Albero Pharma Private Limited
Premium access

Shareholding and investment profile for Umaben Rajankumar Thakar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Umaben Rajankumar Thakar

Umaben Rajankumar Thakar currently holds 1 directorship: Albero Pharma Private Limited (Director, since 19 Aug 2021, revenue ₹1.08 Cr (FY 2025)).

Umaben Rajankumar Thakar was first appointed on 19 Aug 2021 as Director at Albero Pharma Private Limited.

The current boards of Umaben Rajankumar Thakar's companies include Anant Gamanlal Chaudhari (Albero Pharma Private Limited), Chandraben Hiralal Thakkar (Albero Pharma Private Limited), Karunendra Pandey (Albero Pharma Private Limited), Vishal Rajendrabhai Chaudhari (Albero Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available